Evoke Pharma (EVOK) Misses Q2 EPS by 62c

Evoke Pharma (NASDAQ: EVOK) reported Q2 EPS of ($0.62). Revenue for the quarter came in at $3.75 million.

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Deutsche Bank Downgrades argenx SE (ARGX:BB) (ARGX) to Hold
• Pinduoduo (PDD) Tops Q2 EPS by 98c
• United States Oil Fund (USO) call put ratio 1.7 calls to 1 put as share price down 1.7%